The company reported strong performance across key product portfolios ... In the vaccines segment, GlaxoSmithKline Pharmaceuticals maintained leadership in the self-pay private market for ...

With these trends in view, let’s look at the 7 most undervalued biotech stocks to invest in.

The court directed the firm to pay Ms Gichuki 10 months’ salary as compensation would be adequate in the circumstances ...

The company anticipates five new product approvals in 2025 ... sales target to over £40 billion. Overall GSK ranks 5th on our list of the cheap pharmaceutical stocks to buy according to analysts.

The annual per capita pharmaceutical sales are less than US$32. Most of this spent is out of the pocket. By providing a big portfolio of 140 products with a relative low price, GSK is winning the ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other best ... “This may be the largest opportunity we’ve ever seen in the pharmaceutical industry.” Medication ...

One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...

Shares of clinical-stage biotech Chimerix skyrocketed following an acquisition agreement from Jazz Pharmaceuticals for $8.55 per share in cash, aggregating to nearly $935 million. The offer price ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary ... Also, they introduced the Animal health products. In the year 1971, the company built the Research & development laboratory at Thane.

Pharmaceutical companies are currently granted at least eight years’ “protection” over their data from research and clinical ...

The National Agency for Food and Drug Administration and Control has uncovered a massive stockpile of falsified and unregistered pharmaceutical products ... and counterfeit GSK Ampiclox, were ...